{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:52:54Z","timestamp":1791265974826,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301602"],"award-info":[{"award-number":["82301602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2024NSFSC1642"],"award-info":[{"award-number":["2024NSFSC1642"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Magnetic resonance imaging (MRI) markers are identified as important indicators for the diagnosis of multiple system atrophy (MSA). However, whether these MRI markers can predict the disease progression of MSA remains undefined. We aimed to investigate the relationship between MRI markers and disease progression in patients with early MSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The patients were divided into MRI-positive and MRI-negative groups based on MSA-specific MRI markers. Disease progression was evaluated using the Unified MSA Rating Scale (UMSARS), Montreal Cognitive Assessment, and Frontal Assessment Battery. A repeated measures ANCOVA was used to compare the rate of disease progression between the two groups. A multiple linear regression model was used to assess the association between MRI subtype and disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 144 patients with early MSA were enrolled, and 73 patients completed the 2-year follow-up. Patients with MSA and MSA of the parkinsonian subtype (MSA-P) in the MRI-positive group exhibited significantly faster disease progression on the total UMSARS score over a 2-year follow-up compared to those in the MRI-negative group (p\u2009=\u2009.002 and p\u2009=\u2009.020, respectively). Multiple linear regression analysis revealed that MRI-positive status was a significant predictor of more severe disease progression on the UMSARS total score in patients with MSA and MSA-P at the 1- and 2-year follow-up after adjusting for age, sex, and baseline disease duration (all p\u2009&amp;lt;\u2009.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights that MRI markers are valuable imaging predictors of disease progression in early MSA, in addition to their diagnostic role.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/gerona\/glag194","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:42:31Z","timestamp":1785843751000},"source":"Crossref","is-referenced-by-count":0,"title":["Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort study"],"prefix":"10.1093","volume":"81","author":[{"given":"Lingyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]},{"name":"Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwei","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirui","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-7404","authenticated-orcid":false,"given":"Xueping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026100601012263000_glag194-B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2026100601012263000_glag194-B2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12916-022-02645-1","article-title":"Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"2026100601012263000_glag194-B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.28847","article-title":"Neurofilament light chain predicts disease severity and progression in multiple system atrophy","volume":"37","author":"Zhang","year":"2022","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B4","doi-asserted-by":"publisher","first-page":"104813","DOI":"10.1016\/j.nbd.2020.104813","article-title":"Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study","volume":"139","author":"Foubert-Samier","year":"2020","journal-title":"Neurobiol Dis"},{"key":"2026100601012263000_glag194-B5","doi-asserted-by":"publisher","first-page":"100183","DOI":"10.1016\/j.prdoa.2023.100183","article-title":"Prediction of early-wheelchair dependence in multiple system atrophy based on machine learning algorithm: a prospective cohort study","volume":"8","author":"Zhang","year":"2023","journal-title":"Clin Park Relat Disord"},{"key":"2026100601012263000_glag194-B6","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study","volume":"142","author":"Miki","year":"2019","journal-title":"Brain"},{"key":"2026100601012263000_glag194-B7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"2026100601012263000_glag194-B8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.14336\/ad.2017.0711","article-title":"Causes of death in Chinese patients with multiple system atrophy","volume":"9","author":"Zhang","year":"2018","journal-title":"Aging Dis"},{"key":"2026100601012263000_glag194-B9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/s1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol"},{"key":"2026100601012263000_glag194-B10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"key":"2026100601012263000_glag194-B11","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","article-title":"GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)","volume":"271","author":"Katzdobler","year":"2024","journal-title":"J Neurol"},{"key":"2026100601012263000_glag194-B12","doi-asserted-by":"publisher","first-page":"1069837","DOI":"10.3389\/fnagi.2022.1069837","article-title":"Cystatin C predicts cognitive decline in multiple system atrophy: a 1-year prospective cohort study","volume":"14","author":"Zhang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"2026100601012263000_glag194-B13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00702-025-02964-6","article-title":"The role of neuro-imaging in multiple system atrophy","volume":"133","author":"Krismer","year":"2026","journal-title":"J Neural Transm (Vienna)"},{"key":"2026100601012263000_glag194-B14","doi-asserted-by":"publisher","first-page":"105287","DOI":"10.1016\/j.parkreldis.2023.105287","article-title":"Comparison of mean diffusivity, R2* relaxation rate and morphometric biomarkers for the clinical differentiation of parkinsonism","volume":"108","author":"Chougar","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"2026100601012263000_glag194-B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mdc3.13354","article-title":"Pragmatic approach on neuroimaging techniques for the differential diagnosis of parkinsonisms","volume":"9","author":"Peralta","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"2026100601012263000_glag194-B16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/mds.28204","article-title":"A standardized MR imaging protocol for parkinsonism","volume":"35","author":"Reim\u00e3o","year":"2020","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mdc3.13052","article-title":"Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? A systematic review and recommendations by the movement disorder society multiple system atrophy study group","volume":"7","author":"Pellecchia","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"2026100601012263000_glag194-B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.irn.2018.08.010","article-title":"Structural imaging in atypical parkinsonism","volume":"142","author":"Heim","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"2026100601012263000_glag194-B19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2018.08.016","article-title":"What a neurologist should know about PET and SPECT functional imaging for parkinsonism: a practical perspective","volume":"59","author":"Thobois","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2026100601012263000_glag194-B20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2018.08.004","article-title":"Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy","volume":"58","author":"Krismer","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2026100601012263000_glag194-B22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"2026100601012263000_glag194-B23","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/jnnp-2014-309999","article-title":"New insights into orthostatic hypotension in multiple system atrophy: a European multicenter cohort study","volume":"87","author":"Pavy-Le Traon","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026100601012263000_glag194-B25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"2026100601012263000_glag194-B26","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"12","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"2026100601012263000_glag194-B27","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/jnnp.2010.214890","article-title":"A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability","volume":"82","author":"Rolland","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026100601012263000_glag194-B28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3233\/jpd-202332","article-title":"Progression of motor and non-motor symptoms in multiple system atrophy: a prospective study from the Catalan-MSA registry","volume":"11","author":"P\u00e9rez-Soriano","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"2026100601012263000_glag194-B29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.70028","article-title":"Disease progression in multiple system atrophy: the ASPIRE multi-modal biomarker study","volume":"99","author":"Fabbri","year":"2026","journal-title":"Ann Neurol"},{"key":"2026100601012263000_glag194-B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.28923","article-title":"mTOR inhibition with sirolimus in multiple system atrophy: a randomized, double-blind, placebo-controlled futility trial and 1-year biomarker longitudinal analysis","volume":"37","author":"Palma","year":"2022","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B31","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/j.acra.2024.01.006","article-title":"Advanced cognitive patterns in multiple system atrophy compared to Parkinson\u2019s disease: an individual diffusion tensor imaging study","volume":"31","author":"Pang","year":"2024","journal-title":"Acad Radiol"},{"key":"2026100601012263000_glag194-B32","doi-asserted-by":"publisher","first-page":"8888255","DOI":"10.1155\/2023\/8888255","article-title":"Association between cognitive impairment and hippocampal subfield volumes in multiple system atrophy","volume":"2023","author":"Sugiyama","year":"2023","journal-title":"Parkinsons Dis"},{"key":"2026100601012263000_glag194-B33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12311-022-01455-8","article-title":"Magnetic resonance T1w\/T2w ratio in the putamen and cerebellum as a marker of cognitive impairment in MSA: a longitudinal study","volume":"22","author":"Cuoco","year":"2023","journal-title":"Cerebellum"},{"key":"2026100601012263000_glag194-B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/rnn-180862","article-title":"Frontal lobe function, behavioral changes and quality of life in patients with multiple system atrophy","volume":"37","author":"Zhang","year":"2019","journal-title":"Restor Neurol Neurosci"},{"key":"2026100601012263000_glag194-B35","doi-asserted-by":"publisher","first-page":"e67896","DOI":"10.7759\/cureus.67896","article-title":"Imaging markers of multiple system atrophy and their association with disease severity: a cross-sectional study","volume":"16","author":"Dash","year":"2024","journal-title":"Cureus"},{"key":"2026100601012263000_glag194-B36","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B37","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.10468","article-title":"Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI","volume":"18","author":"Schott","year":"2003","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.29534","article-title":"Disease progression in multiple system atrophy: the value of clinical cohorts with long follow-up","volume":"38","author":"Saulnier","year":"2023","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B39","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/jad-170397","article-title":"Multiple system atrophy: an oligodendroglioneural synucleinopathy","volume":"62","author":"Jellinger","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"2026100601012263000_glag194-B40","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/mds.30182","article-title":"Trajectories of pontine volume in patients with multiple system atrophy","volume":"40","author":"Kawabata","year":"2025","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.29633","article-title":"Progressive brain atrophy in multiple system atrophy: a longitudinal, multicenter, magnetic resonance imaging study","volume":"39","author":"Krismer","year":"2024","journal-title":"Mov Disord"},{"key":"2026100601012263000_glag194-B42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awl021","article-title":"Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy","volume":"129","author":"Paviour","year":"2006","journal-title":"Brain"},{"key":"2026100601012263000_glag194-B43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.parkreldis.2021.07.007","article-title":"Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank","volume":"89","author":"Koga","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"2026100601012263000_glag194-B44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/wnl.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"}],"container-title":["The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glag194\/70492592\/glag194.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/10\/glag194\/70492592\/glag194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/10\/glag194\/70492592\/glag194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:01:28Z","timestamp":1791262888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/doi\/10.1093\/gerona\/glag194\/8752388"}},"subtitle":[],"editor":[{"given":"Lewis A","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,5]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glag194","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,5]]},"article-number":"glag194"}}